| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +75.00% | +2.19% | +1.35% | +0.84% | -0.71% | — |
| 14d | 4 | +50.00% | +6.82% | +0.79% | +10.26% | +13.28% | — |
| 30d | 4 | +50.00% | +3.32% | +1.49% | +1.83% | +2.33% | — |
| 60d | 4(1 pending) | +100.00% | +0.98% | +4.57% | -3.59% | -7.44% | — |
| 90d | 4(1 pending) | +100.00% | -1.75% | +10.00% | -11.75% | -12.61% | — |
| 180d | 4(2 pending) | +50.00% | +33.50% | +14.19% | +19.31% | +19.31% | — |
| 1y | 4(2 pending) | +0.00% | -36.48% | +29.12% | -65.60% | -65.60% | — |
| 2y | 4(3 pending) | +0.00% | -95.04% | +23.69% | -118.72% | -118.72% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ARVN ARVINAS, INC. | SALE10b5-1 10b5-1 plan | 5,696 | $8.16 | $46.5K | 187,432 | Jun 24, 2026 | Jun 24, 2026 ↗ | View → |
| MIST MILESTONE PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 77,000 | — | — | 77,000 | Jun 10, 2026 | Jun 12, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | SALE Chief Financial Officer | 11,139 | $9.94 | $110.7K | 193,128 | May 11, 2026 | May 13, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 67,000 | — | — | 67,000 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 45,000 | — | — | 204,267 | Feb 26, 2026 | Mar 2, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | SALE Chief Financial Officer | 5,134 | $11.89 | $61.0K | 159,267 | Feb 13, 2026 | Feb 18, 2026 ↗ | View → |
| ARVN ARVINAS, INC. | SALE Chief Financial Officer | 5,700 | $7.61 | $43.4K | 164,401 | Jun 24, 2025 | Jun 24, 2025 ↗ | View → |
| MIST MILESTONE PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 59,600 | — | — | 170,101 | May 9, 2025 | May 13, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 91,000 | — | — | 91,000 | May 9, 2025 | May 13, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 74,960 | — | — | 74,960 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 49,092 | — | — | 110,501 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| MIST MILESTONE PHARMACEUTICALS INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Aug 28, 2024 | Aug 29, 2024 ↗ | View → |
| MIST MILESTONE PHARMACEUTICALS INC. | SALEGRANT Stock grant | 80,000 | — | — | 80,000 | Jul 15, 2024 | Jul 17, 2024 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 61,409 | — | — | 61,409 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| ARVN ARVINAS, INC. | PURCHASEGRANT Stock grant | 94,418 | — | — | 94,418 | Jun 24, 2024 | Jun 26, 2024 ↗ | View → |
| VYNE VYNE THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 3,017 | $3.36 | $10.1K | 116,468 | May 28, 2021 | Jun 2, 2021 ↗ | View → |
| VYNE VYNE THERAPEUTICS INC. | SALE Chief Financial Officer | 762 | $6.84 | $5.2K | 113,451 | Mar 31, 2021 | Apr 2, 2021 ↗ | View → |
| VYNE VYNE THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 29,213 | — | — | 114,213 | Feb 22, 2021 | Feb 24, 2021 ↗ | View → |
| VYNE VYNE THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 68,162 | — | — | 68,162 | Feb 22, 2021 | Feb 24, 2021 ↗ | View → |
| VYNE VYNE THERAPEUTICS INC. | PURCHASE Chief Financial Officer | 40,000 | $1.46 | $58.5K | 340,000 | Sep 8, 2020 | Sep 8, 2020 ↗ | View → |
| PDSB PDS BIOTECHNOLOGY CORP | PURCHASEGRANT Stock grant | 38,400 | $1.30 | $49.9K | 42,549 | Feb 14, 2020 | Feb 19, 2020 ↗ | View → |